Alpa Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹31.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.09 per cent from ₹29.05 crore. This corresponds to a year-on-year *(YoY) decline of 21.34 per cent.
Operating Profit
Operating Profit stands at ₹3.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 138.41 per cent from ₹1.51 crore. This corresponds to a year-on-year *(YoY) growth of 1,700.00 per cent.
PBDT
PBDT stands at ₹3.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 37.08 per cent from ₹2.40 crore. This corresponds to a year-on-year *(YoY) growth of 23.68 per cent.
Profit Before Tax
Profit Before Tax stands at ₹3.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 75.43 per cent from ₹1.75 crore. This corresponds to a year-on-year *(YoY) growth of 47.60 per cent.
Net Profit
Net Profit stands at ₹1.38 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.21 per cent from ₹1.59 crore. This represents a 165.09 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Alpa Laboratories Ltd Earnings
- YOY
- QOQ
Alpa Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Alpa Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Alpa Laboratories Ltd Financial Reports
Alpa Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Alpa Laboratorie | -3.97% | -5.55% | -5.69% | -7.06% | -9.07% | -34.93% |
| Bal Pharma | -2.53% | -0.64% | -4.60% | 11.58% | 9.63% | -2.96% |
| Kimia Bioscien. | 0.07% | 8.88% | -13.04% | -19.72% | -18.84% | -30.25% |
| Lactose (India) | 1.46% | -6.20% | 6.86% | -5.00% | 11.42% | 10.07% |
| Krebs Biochem | -3.62% | -3.22% | 1.77% | 0.34% | -6.03% | -26.45% |
| Pharmaids Pharma | -1.65% | -1.65% | 7.91% | 13.66% | -3.63% | -46.38% |
| Tyche Industries | -0.05% | -17.22% | -18.76% | -23.21% | -13.09% | -23.21% |
Company Info
Company Information
Chairman & Exec. Director : Mahendra Singh Chawla
E D & Wholetime Director : Vitthal Kothana
ED / MD / Promoter : Paresh Chawla
WTD & Executive Director : Pravin C Shah
WTD & Executive Director : Shitul Shah
Independent Non Exe. Director : Pratik Shah
Independent Non Exe. Director : Jyoti Jain
Independent Non Exe. Director : BAHETI SANKET
Independent Non Exe. Director : Sunil Valecha
Independent Non Exe. Director : Pratibha Lunawat